SEED Co.,Ltd. (TYO:7743)

Market Cap	14.71B
Revenue (ttm)	33.23B
Net Income (ttm)	1.09B
Shares Out	30.27M
EPS (ttm)	36.08
PE Ratio	13.47
Forward PE	13.73
Dividend	15.00 (3.11%)
Ex-Dividend Date	Mar 28, 2025

Volume	39,900
Average Volume	50,765
Open	480.00
Previous Close	482.00
Day's Range	480.00 - 487.00
52-Week Range	408.00 - 635.00
Beta	0.05
RSI	64.94
Earnings Date	Aug 8, 2025

About CTI BioPharma

SEED Co.,Ltd. manufactures and sells contact lenses and care products in Japan. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal contact lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1957
• Employees: 985
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7743

Financial Performance

In 2024, SEED Co.,Ltd.'s revenue was 33.23 billion, an increase of 2.58% compared to the previous year's 32.40 billion. Earnings were 1.09 billion, a decrease of -44.40%.